Search results for “Sialoglycoprotein” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 270 patents, we discovered top 64 key players by total patent application. Chiron Corp., Pfizer Inc., Targetech, Inc. are dominant in this area. They take 23.70% of the total patent filing.
Chiron Corp.
California, United States
Patent: 25
Pfizer Inc.
New York, United States
Patent: 21
Targetech, Inc.
Connecticut, United States
Patent: 18
Novartis Vaccines & Diagnostics, Inc.
New Jersey, United States
Patent: 16
Arrowhead Pharmaceuticals, Inc.
California, United States
Patent: 10
Roche Glycart AG
ZURICH, Switzerland
Patent: 10
Nihon Medi-Physics Co., Ltd.
Tokyo-to, Japan
Patent: 9
Mologic Ltd.
United Kingdom
Patent: 9
STARTUP
Avilar Therapeutics, Inc.
Massachusetts, United States
Patent: 7
Argorna Pharmaceuticals Ltd.
China
Patent: 7
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 12 patents, we discovered top 2 start-ups by total patent application.
STARTUP
Avilar Therapeutics, Inc.
Massachusetts, United States
Patent: 7
STARTUP
Lycia Therapeutics, Inc.
California, United States
Patent: 5
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 103 patents applied in the last 5 years. We discover 35 most active companies in this area. The fast-growing National Cerebral & Cardiovascular Center, Arrowhead Pharmaceuticals, Inc., Argorna Pharmaceuticals Ltd. take 22.33% of patent filing during this period.
National Cerebral & Cardiovascular Center
Osaka-fu, Japan
Patent: 8
Arrowhead Pharmaceuticals, Inc.
California, United States
Patent: 8
Argorna Pharmaceuticals Ltd.
China
Patent: 7
STARTUP
Avilar Therapeutics, Inc.
Massachusetts, United States
Patent: 7
Jiangnan University
Jiangsu Sheng, China
Patent: 6
King's College London
United Kingdom
Patent: 6
Arcturus Therapeutics, Inc.
California, United States
Patent: 6
Yale University
Connecticut, United States
Patent: 5
STARTUP
Lycia Therapeutics, Inc.
California, United States
Patent: 5
Osaka University
Osaka-fu, Japan
Patent: 4
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 103 patents in last 5 years, we discover 28 new entrants. National Cerebral & Cardiovascular Center, Argorna Pharmaceuticals Ltd., Avilar Therapeutics, Inc. are the most active new entrants in this area.
National Cerebral & Cardiovascular Center
Osaka-fu, Japan
Patent: 8
Argorna Pharmaceuticals Ltd.
China
Patent: 7
STARTUP
Avilar Therapeutics, Inc.
Massachusetts, United States
Patent: 7
Jiangnan University
Jiangsu Sheng, China
Patent: 6
King's College London
United Kingdom
Patent: 6
Arcturus Therapeutics, Inc.
California, United States
Patent: 6
Yale University
Connecticut, United States
Patent: 5
STARTUP
Lycia Therapeutics, Inc.
California, United States
Patent: 5
Osaka University
Osaka-fu, Japan
Patent: 4
University of Tsukuba
Osaka-fu, Japan
Patent: 3
Research Institutions
Order by:
Innovation Intensity
With the analysis among 155 patents, we discovered top 28 universities and scientific research institutions by total patent application. University of Connecticut, King's College London, Jiangnan University are dominant in this area. They take 47.74% of the total patent filing.
University of Connecticut
Connecticut, United States
Patent: 42
King's College London
United Kingdom
Patent: 6
Jiangnan University
Jiangsu Sheng, China
Patent: 6
Yale University
Connecticut, United States
Patent: 5
The University of Queensland
Queensland, Australia
Patent: 4
The Ohio University
Ohio, United States
Patent: 4
Osaka University
Osaka-fu, Japan
Patent: 4
Charité - Universitätsmedizin Berlin
Berlin, Germany
Patent: 3
University of Tsukuba
Osaka-fu, Japan
Patent: 3
Albert Einstein College of Medicine, Inc.
New York, United States
Patent: 3
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: